NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors No drug interventions treatment 1 recruiting NCT06034860
Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types treatment 1 active_not_recruiting NCT06057935
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma treatment 2 recruiting NCT06638931
Agnostic Therapy in Rare Solid Tumors No drug interventions treatment 2 recruiting NCT05215574
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05579366
PRO1184 for Advanced Solid Tumors No drug interventions treatment 1 / 2 recruiting NCT05960773
Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma treatment 2 recruiting NCT06581549
Immune Microenvironment and Gene Expression Profiling in Mesothelioma No drug interventions Not Available Not Available recruiting NCT01851395
Rapid Autopsy and Procurement of Cancer Tissue No drug interventions Not Available Not Available recruiting NCT01950572
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma No drug interventions Not Available Not Available recruiting NCT02875548
A Study to Assess the Long-term Safety of Tazemetostat treatment 1 / 2 enrolling_by_invitation NCT03830229
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes No drug interventions Not Available Not Available recruiting NCT04242199
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT04431024
Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome No drug interventions Not Available Not Available recruiting NCT04857372
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors No drug interventions treatment 1 recruiting NCT04913337
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies treatment 1 / 2 active_not_recruiting NCT05005429
Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma treatment 2 completed NCT06444815
A Study of VET3-TGI in Patients With Solid Tumors treatment 1 recruiting NCT04450043
The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance No drug interventions supportive_care Not Available unknown_status NCT00295503
Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma treatment 2 completed NCT01997190
Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion treatment 1 completed NCT00188890
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers No drug interventions Not Available Not Available completed NCT01362790
SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma treatment 1 / 2 completed NCT01119664
Combination Gene Transfer and Chemotherapy No drug interventions treatment 1 completed NCT03655821
Dose Individualization of Pemetrexed - IMPROVE-II treatment 4 terminated NCT00128102
Suberoylanilide Hydroxamic Acid (Vorinostat, MK-0683) Versus Placebo in Advanced Malignant Pleural Mesothelioma (MK-0683-014) treatment 3 completed NCT06491784
EXTRA-Meso (EXercise TheRApy in Mesothelioma) Feasibility No drug interventions other Not Available recruiting NCT00629343
Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide treatment 1 unknown_status NCT02758587
Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) treatment 1 / 2 unknown_status NCT06466187
A Study of SGN-MesoC2 in Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. No drug interventions treatment 1 completed NCT04115254
Stereotactic Magnetic Resonance Guided Radiation Therapy No drug interventions treatment Not Available suspended NCT03652077
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies treatment 1 completed NCT00061477
Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma treatment 2 completed NCT05070247
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors treatment 1 / 2 recruiting NCT01912547
Thromboelastography During Surgery for Malignant Pleural Mesothelioma No drug interventions Not Available Not Available unknown_status NCT02838745
Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM other 1 terminated NCT01604005
PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma No drug interventions prevention 3 terminated NCT02029105
Serum Biomarkers in Diagnosis of Mesothelioma Not Available Not Available completed NCT02293005
Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma treatment 2 completed NCT00101283
Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma treatment 2 completed NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors treatment 1 recruiting NCT03538028
A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies treatment 1 completed NCT00715611
Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma treatment 2 active_not_recruiting NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers treatment 2 recruiting NCT02784171
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma treatment 2 / 3 active_not_recruiting NCT03881488
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies treatment 1 active_not_recruiting NCT00651456
Mesothelioma Avastin Plus Pemetrexed-cisplatin Study treatment 2 / 3 completed NCT00748085
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD) No drug interventions treatment Not Available terminated NCT04537715
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels treatment 1 completed NCT04840615
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma treatment 1 terminated NCT04214015
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma No drug interventions Not Available Not Available unknown_status NCT04940637
UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC treatment 2 recruiting NCT02611037
Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma treatment 2 active_not_recruiting NCT03436732
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma treatment 1 terminated NCT03918252
Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma treatment 2 active_not_recruiting NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT02511600
Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing Decortication No drug interventions treatment 3 withdrawn NCT01281800
Cisplatin With Alimta or Gemcitabine in Long Infusion for Mesothelioma No drug interventions treatment 2 unknown_status NCT02073500
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies No drug interventions Not Available Not Available recruiting NCT05245500
Phase 1/2 Study of MRTX1719 in Solid Tumors With MTAP Deletion treatment 1 / 2 recruiting NCT02661100
A Trial of CDX-1401 in Combination With Poly-ICLC and Pembrolizumab, in Previously Treated Advanced Solid Tumor Patients treatment 1 / 2 withdrawn NCT00407459
Phase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesothelioma treatment 2 completed NCT00794859
Sorafenib in Previously Treated Malignant Mesothelioma treatment 2 unknown_status NCT00668499
A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma treatment 1 / 2 withdrawn NCT02613299
Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma No drug interventions Not Available Not Available recruiting NCT03638206
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies No drug interventions treatment 1 / 2 unknown_status NCT02798536
Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma treatment 1 completed NCT04515836
Olaparib in Patients With HRD Malignant Mesothelioma treatment 2 recruiting NCT03023319
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors treatment 1 completed NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT02648763
Staging Procedures to Diagnose Malignant Pleural Mesothelioma No drug interventions Not Available Not Available recruiting NCT04792463
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome No drug interventions Not Available Not Available recruiting NCT02860286
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma treatment 2 completed NCT01188486
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer device_feasibility Not Available terminated NCT01385722
Molecular Analysis of Thoracic Malignancies No drug interventions Not Available Not Available enrolling_by_invitation NCT05404022
Feasibility Trial of a Personalised Nutrition and Activity Programme for People With Lung Cancer Over 65 Years No drug interventions treatment Not Available completed NCT00040625
ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma. Not Available Not Available approved_for_marketing NCT05461430
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) No drug interventions Not Available Not Available recruiting NCT00895648
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma treatment 2 terminated NCT04985357
Defining the Clinical Potential of Mass Response as a Biomarker for Patient Tumor Sensitivity to Drugs No drug interventions Not Available Not Available not_yet_recruiting NCT02688166
Cardiac MRI Biomarker Testing (GCC 1618) No drug interventions Not Available Not Available terminated NCT04040231
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma treatment 1 active_not_recruiting NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT06452160
A Study of BGC515 Capsules in Subjects With Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT06196294
GPC3/Mesothelin-CAR-γδT Cells Against Cancers treatment 1 recruiting NCT00190762
A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma treatment 3 completed NCT03683680
Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers No drug interventions diagnostic Not Available recruiting NCT01445392
SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma treatment 1 terminated NCT04300244
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma treatment 2 active_not_recruiting NCT02610140
Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM) treatment 2 completed NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) treatment 2 recruiting NCT04375267
177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours treatment 1 active_not_recruiting NCT04429204
Cryoablation for the Promotion of Local Tumor Infiltration in Patients With Mesothelioma No drug interventions treatment Not Available withdrawn NCT02139904
Vinorelbine in Mesothelioma treatment 2 completed NCT00685204
An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma treatment 2 unknown_status NCT02040272
Mesothelioma and Radical Surgery 2 No drug interventions treatment Not Available unknown_status NCT02716272
Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) Patients treatment 2 completed NCT01590472
Do Your Genes Put You at a Higher Risk of Developing Mesothelioma No drug interventions Not Available Not Available completed NCT00859469
Eloxatin® Plus Gemcitabine Chemotherapy for Mesothelioma treatment 2 completed NCT02385812
Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma No drug interventions screening 2 terminated NCT02709512
Ph 2/3 Study in Subjects With MPM to Assess ADI-PEG 20 With Pemetrexed and Cisplatin treatment 2 / 3 completed NCT00787410
An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma treatment 2 completed NCT05228795
Glypican-1 Expression in Epithelioid Mesothelioma, Adenocarcinoma and SCC of the Lung No drug interventions Not Available Not Available unknown_status NCT02899195
Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma treatment 2 completed NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Subjects With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression No drug interventions treatment 1 / 2 recruiting NCT02903914
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors treatment 1 / 2 completed NCT03644550
Anti-Mesothelin Immunotoxin LMB-100 Followed by Pembrolizumab in Malignant Mesothelioma treatment 2 terminated NCT01204203
Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901) treatment 2 completed NCT01624090
Mithramycin for Lung, Esophagus, and Other Chest Cancers treatment 2 terminated NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT02395679
Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma Patients No drug interventions treatment 1 unknown_status NCT06536179
New Preclinical and Clinical Approaches to Mesothelioma No drug interventions Not Available Not Available recruiting NCT03983954
Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT01413451
Amatuximab for High Mesothelin Cancers treatment 0 terminated NCT01356251
Psychosocial Needs and Exploration of Online Support for Patients With Mesothelioma No drug interventions supportive_care Not Available completed NCT02592551
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma other 2 completed NCT00535951
Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma treatment 1 completed NCT06010277
Folinic Acid for Prevention of Pemetrexed-induced Toxicity prevention 4 recruiting NCT00004547
Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy treatment 2 completed NCT03207347
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) treatment 2 completed NCT05415098
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas No drug interventions treatment 1 recruiting NCT02748798
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders diagnostic 0 recruiting NCT02958683
Chest Wall Motion Analysis in Disease No drug interventions Not Available Not Available completed NCT00604461
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM) treatment 1 / 2 terminated NCT03556228
Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma treatment 1 recruiting NCT04301011
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors treatment 1 / 2 terminated NCT06310993
Exercise to Boost Immunity in Advanced Cancer No drug interventions treatment Not Available not_yet_recruiting NCT00094978
Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum treatment 1 terminated NCT03867578
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma No drug interventions screening Not Available completed NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors treatment 1 completed NCT01401907
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies No drug interventions supportive_care Not Available completed NCT01776385
The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural Mesothelioma No drug interventions prevention Not Available completed NCT00996385
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma treatment 2 unknown_status NCT02859415
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases treatment 1 / 2 terminated NCT03319537
Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma treatment 1 / 2 terminated NCT02062632
Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy supportive_care 2 terminated NCT00551252
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma treatment 2 unknown_status NCT02078700
Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. No drug interventions supportive_care 2 completed NCT01907100
Nintedanib (BIBF 1120) in Mesothelioma treatment 2 / 3 terminated NCT04334759
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma treatment 3 active_not_recruiting NCT05278975
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma treatment 1 / 2 recruiting NCT04028570
A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection No drug interventions treatment Not Available active_not_recruiting NCT05932199
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma treatment 1 / 2 recruiting NCT02899299
Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients treatment 3 completed NCT02012699
Integrated Cancer Repository for Cancer Research No drug interventions Not Available Not Available recruiting NCT04665206
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 or mNF2 Gene Mutations No drug interventions treatment 1 / 2 recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT03656549
Dose Individualization of Pemetrexed - IMPROVE-I treatment 2 completed NCT01135849
B-Receptor Signaling in Cardiomyopathy No drug interventions Not Available Not Available completed NCT02948413
Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials No drug interventions Not Available Not Available completed NCT04234113
Study of SO-C101 and SO-C101 in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors treatment 1 active_not_recruiting NCT05311618
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors treatment 1 active_not_recruiting NCT06090318
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss treatment 1 / 2 withdrawn NCT06477419
A Study of Sacituzumab Govitecan in People With Mesothelioma treatment 2 recruiting NCT01569919
A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma treatment 2 unknown_status NCT00454519
Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis No drug interventions treatment 2 unknown_status NCT04981119
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing No drug interventions Not Available Not Available recruiting NCT03655834
Dose Individualization of Pemetrexed - IMPROVE-III diagnostic 4 completed NCT04272034
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors No drug interventions treatment 1 active_not_recruiting NCT00637624
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy prevention Not Available terminated NCT00597116
An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma treatment 2 terminated NCT05730816
MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI prevention 2 recruiting NCT00469196
Tomotherapy Treatment for Mesothelioma No drug interventions treatment 2 completed NCT02628535
Safety Study of MGD009 in B7-H3-expressing Tumors No drug interventions treatment 1 terminated NCT04088786
Phase I Trial HIPEC With Nal-irinotecan treatment 1 completed NCT01583686
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer treatment 1 / 2 terminated NCT00785239
CryoSpray Ablation(tm)Thoracic Patient Registry No drug interventions Not Available Not Available withdrawn NCT00316225
Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen treatment 2 completed NCT01521325
A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers basic_science 1 completed NCT00137826
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma treatment 2 completed NCT02467426
Isolated Thoracic Perfusion (ITP-F) for MPM Not Available Not Available completed NCT04056026
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma treatment 0 completed NCT00402766
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma treatment 1 completed NCT04153565
A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17) treatment 1 completed NCT04631731
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity No drug interventions diagnostic 1 / 2 recruiting NCT03560973
A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM treatment 2 unknown_status NCT03075527
A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma treatment 2 suspended NCT04802876
Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors treatment 2 recruiting NCT06538376
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU No drug interventions diagnostic Not Available recruiting NCT03610360
DENdritic Cell Immunotherapy for Mesothelioma No drug interventions treatment 2 / 3 completed NCT00325494
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer treatment 1 completed NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors treatment 1 terminated NCT02071862
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors treatment 1 completed NCT04489862
αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors No drug interventions treatment 0 unknown_status NCT05041062
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma treatment 2 completed NCT05819580
Studying the Clinical Trial Experiences of Patients With Mesothelioma No drug interventions Not Available Not Available not_yet_recruiting NCT05544929
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers treatment 1 recruiting NCT04316689
First-in-human Study of S-588210 (S-488210+S-488211) No drug interventions treatment 1 completed NCT03531840
Olaparib in People With Malignant Mesothelioma treatment 2 completed NCT02464904
Intrapleural Cryotherapy for Malignant Pleural Mesothelioma No drug interventions treatment Not Available terminated NCT04481672
Intravenous Magnesium in Patients Receiving Cisplatin supportive_care 1 completed NCT01719068
Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos No drug interventions Not Available Not Available unknown_status NCT02414269
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin treatment 1 / 2 active_not_recruiting NCT01134146
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT) No drug interventions treatment 1 completed NCT02613312
Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural Mesothelioma No drug interventions Not Available Not Available terminated NCT04804410
Dielectric Properties of Matched Tissue Samples From Thoracic Malignancies and Corresponding Normal Tissues No drug interventions treatment Not Available unknown_status NCT01627795
Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment No drug interventions treatment 1 / 2 suspended NCT03063450
CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma treatment 3 active_not_recruiting NCT00703638
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT04345705
Direct Injection of Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma treatment 1 not_yet_recruiting NCT02349958
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy No drug interventions treatment 2 unknown_status